Get the Stockscreener App
277.40
2.44%
-6.93
After Hours:
276.70
-0.70
-0.25%
Overview
News
Price History
Option Chain
Financials
Why CI Down?
Discussions
Forecast
Stock Split
Dividend History
Cigna Group stock is traded at $277.40, with a volume of 2.40M.
It is down -2.44% in the last 24 hours and down -5.10% over the past month.
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense, and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 16 million US and 2 million international medical members covered as of December 2025.
See More
Previous Close:
$284.33
Open:
$284.2
24h Volume:
2.40M
Relative Volume:
1.43
Market Cap:
$73.38B
Revenue:
$278.13B
Net Income/Loss:
$6.74B
P/E Ratio:
11.75
EPS:
23.6047
Net Cash Flow:
$7.66B
1W Performance:
-3.09%
1M Performance:
-5.10%
6M Performance:
+0.04%
1Y Performance:
-11.10%
1-Day Range:
$276.14
$287.31
1-Week Range:
$276.14
$288.67
52-Week Range:
$239.51
$338.89
Cigna Group Stock (CI) Company Profile
Name
Cigna Group
Sector
Industry
Phone
(860) 226-6000
Address
900 COTTAGE GROVE ROAD, BLOOMFIELD, CT
Compare CI vs UNH, CVS, ELV, HUM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CI
Cigna Group
|
277.40 | 75.21B | 278.13B | 6.74B | 7.66B | 23.60 |
UNH
Unitedhealth Group Inc
|
380.31 | 347.39B | 449.71B | 12.81B | 19.67B | 13.24 |
CVS
Cvs Health Corp
|
90.98 | 118.62B | 407.94B | 2.90B | 7.39B | 2.2771 |
ELV
Elevance Health Inc
|
393.19 | 85.29B | 200.42B | 5.24B | 6.45B | 23.50 |
HUM
Humana Inc
|
305.42 | 37.06B | 137.20B | 1.15B | 1.27B | 9.3439 |
Cigna Group Stock (CI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-12-26 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Oct-14-25 | Initiated | Goldman | Buy |
| Feb-06-25 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Jun-26-24 | Initiated | Piper Sandler | Overweight |
| May-30-24 | Initiated | Robert W. Baird | Outperform |
| Mar-06-24 | Initiated | Barclays | Overweight |
| Feb-05-24 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Feb-05-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Feb-01-24 | Upgrade | Deutsche Bank | Hold → Buy |
| Jan-04-24 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Dec-11-23 | Upgrade | Jefferies | Hold → Buy |
| Aug-18-23 | Downgrade | Edward Jones | Buy → Hold |
| Jun-06-23 | Upgrade | BofA Securities | Neutral → Buy |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Neutral |
| Apr-05-23 | Upgrade | Raymond James | Outperform → Strong Buy |
| Jan-03-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Nov-23-22 | Resumed | Morgan Stanley | Overweight |
| Nov-21-22 | Downgrade | Raymond James | Strong Buy → Outperform |
| Jul-14-22 | Downgrade | Jefferies | Buy → Hold |
| Jun-22-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jun-17-22 | Initiated | Loop Capital | Hold |
| May-27-22 | Resumed | Bernstein | Mkt Perform |
| May-26-22 | Upgrade | BofA Securities | Underperform → Neutral |
| May-16-22 | Upgrade | JP Morgan | Neutral → Overweight |
| May-09-22 | Upgrade | Cowen | Market Perform → Outperform |
| Feb-07-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Feb-04-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jan-06-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-21-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-16-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Dec-14-21 | Initiated | Goldman | Neutral |
| Nov-17-21 | Initiated | Seaport Research Partners | Buy |
| Sep-27-21 | Initiated | SVB Leerink | Mkt Perform |
| Sep-10-21 | Downgrade | BofA Securities | Buy → Underperform |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| Aug-06-21 | Reiterated | BofA Securities | Buy |
| Aug-06-21 | Reiterated | Citigroup | Buy |
| Aug-06-21 | Reiterated | Deutsche Bank | Buy |
| Aug-06-21 | Reiterated | Jefferies | Buy |
| Aug-06-21 | Reiterated | Mizuho | Buy |
| Aug-06-21 | Reiterated | Oppenheimer | Outperform |
| Aug-06-21 | Reiterated | Truist | Buy |
| May-19-21 | Initiated | Wells Fargo | Equal Weight |
| Jul-01-20 | Initiated | SVB Leerink | Mkt Perform |
| May-04-20 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Mar-24-20 | Upgrade | Raymond James | Outperform → Strong Buy |
| Dec-11-19 | Downgrade | Wells Fargo | Market Perform → Underperform |
| Oct-18-19 | Initiated | Mizuho | Buy |
| Sep-30-19 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Sep-12-19 | Initiated | Deutsche Bank | Buy |
| Aug-06-19 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Apr-23-19 | Initiated | UBS | Buy |
| Jan-14-19 | Initiated | Stephens | Overweight |
| Dec-24-18 | Initiated | Edward Jones | Buy |
| Mar-13-18 | Initiated | Bernstein | Mkt Perform |
| Mar-08-18 | Initiated | Barclays | Overweight |
| Jan-03-18 | Initiated | Goldman | Neutral |
| Nov-03-17 | Reiterated | RBC Capital Mkts | Outperform |
| Jun-22-17 | Reiterated | RBC Capital Mkts | Outperform |
| Jun-12-17 | Initiated | Credit Suisse | Outperform |
| Jun-07-17 | Initiated | Morgan Stanley | Overweight |
| May-08-17 | Reiterated | RBC Capital Mkts | Outperform |
| Apr-05-17 | Initiated | Deutsche Bank | Buy |
View All
Cigna Group Stock (CI) Latest News
Cigna Group stock (US1255231003): shares steady as investors digest recent earnings and outlook - AD HOC NEWS
Barclays Downgrades Cigna (CI), Flags Risks around PBM Transition - Insider Monkey
Cigna Group 1Q Evernorth Health Services Adj. Revenue $58.44B >CI - Moomoo
Top Cigna Group (CI) Competitors 2026 - MarketBeat
Here’s Why Cigna (CI) is Among the 12 Most Undervalued Stocks to Invest In - Yahoo Finance
The Cigna Group stock (US1255091092): Analyst consensus and valuation picture on NYSE CI - AD HOC NEWS
Layoffs, closures tracker: Arkansas system to cut 86 employees - Modern Healthcare
A Look At Cigna Group’s (CI) Valuation After Recent Mixed Share Price Performance - simplywall.st
Cigna Group stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Loneliness in America 2025 - The Cigna Group Newsroom
MJH Life Sciences® recognized with 2025 Cigna Healthy Workforce Designation™ - The Manila Times
Bernstein Maintains Cigna Group(CI.US) With Buy Rating, Maintains Target Price $371 - Moomoo
Cigna (CI) Has a 2026 Growth Story That Looks Bigger Than Medical Costs - AlphaStreet
Centene Gains Inclusion on BofA's US 1 List, Cigna Excluded (CI) - GuruFocus
Does Strong Q1 Beat And Outlook Shift Change The Bull Case For Cigna Group (CI)? - simplywall.st
Cigna Group stock outperforms competitors despite losses on the day - MarketWatch
Cigna Group Cut to Equal-Weight From Overweight by Barclays - Moomoo
Cigna Group Shares Fall After Barclays Downgrade - Moomoo
Midlands hospital system reaches agreement to be back in-network with large insurance provider - Post and Courier
The Cigna Group (CI) Stock Price, Trades & News - GuruFocus
Cigna Group Price Target Cut to $304.00/Share From $310.00 by Barclays - Moomoo
Cigna falls following Barclays downgrade - MSN
Here Are Tuesday’s Top Wall Street Analyst Research Calls: Albemarle, Booz Allen Hamilton, Cigna, DT Midstream, GE Vernova, Intel, Okta, Travelers, Occidental Petroleum, and More - 24/7 Wall St.
Cigna (CI) Downgraded by Barclays Amid Concerns - GuruFocus
Diving deeper into water safety for children with sickle cell disease - The Cigna Group Newsroom
Cigna’s SWOT analysis: stock navigates PBM transition amid policy shifts By Investing.com - Investing.com Nigeria
Cigna’s SWOT analysis: stock navigates PBM transition amid policy shifts - Investing.com
Is The Cigna Group (CI) One of the Best Dividend Growth Stocks to Buy and Hold for 3 Years? - Insider Monkey
The Cigna Group (CI) Downgraded to ‘Hold’ at Deutsche Bank Amid “Multi-Year Uncertainty” - Yahoo Finance
A Look At Cigna Group’s (CI) Valuation After Recent Share Price Gains - Yahoo Finance
Cigna Group stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Lee Appoints Five Memphians to Schools Oversight Board - Memphis Flyer
Cigna Group stock (US1255231003): health insurer focuses on growth after recent earnings - AD HOC NEWS
StockStory Analysis: Victoria's Secret, Napco Security, and Cigna GroupNews and Statistics - IndexBox
Deutsche Bank downgrades Cigna Group (CI) - MSN
Cigna Group stock (US1255231003): Analyst downgrade puts recent momentum to the test - AD HOC NEWS
Cigna Group stock underperforms Wednesday when compared to competitors - MarketWatch
NBT Bank Recognized With 2025 Cigna Healthy Workforce Designation - The Evening Sun | Chenango County, NY's Hometown Newspaper
Cigna Workers Advance 401(k) Forfeiture, Stable Value Fund Suit - Bloomberg Law News
This Cigna Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Wednesday - Benzinga
Anisha Vaz Joins Cigna Healthcare as Head of Human Resources – India - hrtoday.in
Cigna Healthcare gets Anisha Vaz as head-HR, India - HR Katha
Cigna Group stock (US1255231003): dividend date in focus after strong run - AD HOC NEWS
Cigna Group stock (US1255231003): dividend date approaches as health insurer focuses on steady growt - AD HOC NEWS
Cigna Healthcare names Anisha Vaz to lead India HR operations - People Matters Media
Inverclyde MSP 'extremely frustrated' by Cigna's lack of engagement on job cuts - Greenock Telegraph
Cigna Can't Knock Out 401(k) Forfeiture, Fund Suit - Law360
Cigna Group stock outperforms competitors on strong trading day - MarketWatch
NBT Bank Recognized with 2025 Cigna Healthy Workforce Designation - BusinessWest
AI Is Coming for Pharmacy Benefit Managers: Potential Winners and Losers - 24/7 Wall St.
Cigna Group stock (US1255231003): Q1 2026 earnings and outlook keep the health insurer in focus - AD HOC NEWS
Cigna Group Stock (CI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.11%
1.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):